HuGE Literature Finder
Records
1
-
4
Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy. BMC medicine 2021 Jul 19 (1): 154. Long Junyu, Wang Dongxu, Yang Xu, Wang Anqiang, Lin Yu, Zheng Mingjun, Zhang Haohai, Sang Xinting, Wang Hanping, Hu Ke, Zhao Hait |
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
Association between single nucleotide polymorphisms of NOTCH signaling pathway-related genes and the prognosis of NSCLC. Cancer management and research 2019 11 6895-6905. Xu Qiuping, Lin Danhua, Li Xu, Xiao Rendong, Liu Zhiqiang, Xiong Weimin, Cai Lin, He F |
[Association between polymorphism in notch signaling pathway and lung cancer risk]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2018 Mar 52 (3): 243-252. Xu Q P, Xiao R D, Xiong W M, He F, Cai |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: